TENAX THERAPEUTICS, INC. Proceeds from Operating Activities
TENAX THERAPEUTICS, INC. (TENX) reported Proceeds from Operating Activities of $5.90 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:ProceedsFromOperatingActivities · last filed 2024-03-28
- TENAX THERAPEUTICS, INC. proceeds from operating activities for the quarter ending 2023-12-31 was $1.20M.
- TENAX THERAPEUTICS, INC. proceeds from operating activities for the quarter ending 2023-09-30 was $2.10M.
- TENAX THERAPEUTICS, INC. proceeds from operating activities for the quarter ending 2023-06-30 was $700.00K, a 80.00% decline year-over-year.
- TENAX THERAPEUTICS, INC. proceeds from operating activities for the quarter ending 2023-03-31 was $1.90M, a 34.48% decline year-over-year.
- TENAX THERAPEUTICS, INC. proceeds from operating activities for fiscal 2023 was $5.90M, a 48.16% decline from fiscal 2022.
- TENAX THERAPEUTICS, INC. proceeds from operating activities for fiscal 2022 was $11.39M.
| Period end | Proceeds from Operating Activities 3 month | Proceeds from Operating Activities 6 month | Proceeds from Operating Activities 9 month | Proceeds from Operating Activities 12 month |
|---|---|---|---|---|
| 2023-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $3.30M derived: sum of 2 quarters · filed 2024-03-28 | $4.00M derived: sum of 3 quarters · filed 2024-03-28 | $5.90M 10-K · filed 2024-03-28 |
| 2023-09-30 | $2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.80M derived: sum of 2 quarters · filed 2023-11-13 | $4.70M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.60M 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | $1.90M 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | $11.39M 10-K · filed 2024-03-28 | |||
| 2022-06-30 | $3.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $6.40M 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $2.90M 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |